A detailed history of Ethic Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ethic Inc. holds 17,383 shares of PACB stock, worth $33,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,383
Holding current value
$33,896
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.17 $20,859 - $37,721
17,383 New
17,383 $29,000
Q1 2024

May 13, 2024

BUY
$3.52 - $9.59 $1,985 - $5,408
564 Added 3.35%
17,383 $65,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $3,970 - $6,889
-665 Reduced 3.8%
16,819 $164,000
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $1,497 - $2,535
-182 Reduced 1.03%
17,484 $145,000
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $3,250 - $4,580
326 Added 1.88%
17,666 $234,000
Q1 2023

May 12, 2023

SELL
$7.94 - $12.02 $1,913 - $2,896
-241 Reduced 1.37%
17,340 $200,000
Q4 2022

Feb 14, 2023

BUY
$5.67 - $11.2 $99,684 - $196,907
17,581 New
17,581 $143,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Ethic Inc. Portfolio

Follow Ethic Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.